Study Demonstrates GeneSight Psychotropic Test Better Predicts Blood Drug Levels
GeneSight’s combinatorial pharmacogenomic testing approach evaluates how variations in multiple genes may influence an individual’s outcomes with medications.
Read MorePosted by Laurie Bonner | Jun 10, 2020 | Uncategorized |
GeneSight’s combinatorial pharmacogenomic testing approach evaluates how variations in multiple genes may influence an individual’s outcomes with medications.
Read MorePosted by Steve Halasey | Jun 9, 2020 | Uncategorized |
The company will use a new technology to develop a blood test for the detection of early-stage cancer.
Read MorePosted by Laurie Bonner | Jun 5, 2020 | Uncategorized |
Prenatal research into fetal anomalies helps support the management of pregnancy, labor, and appropriate pre- and postnatal treatment.
Read MorePosted by Laurie Bonner | Jun 3, 2020 | Covid 19 |
More than 100 clinical laboratory professionals across the United States provided feedback on covid-19 diagnostic testing and offered recommendations to improve future pandemic responses.
Read MorePosted by Laurie Bonner | Jun 1, 2020 | Company News |
The acquisition provides Roche access to Stratos Genomics’ unique chemistry, sequencing by expansion.
Read More